Background While it is now apparent clinical sequelae (long COVID) may persist after acute
COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to …

Evidence shows that a substantial proportion of patients with COVID-19 experiences long-
term consequences of the disease, but the predisposing factors are poorly understood. We …

With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential
to inform health and social care support. A Scottish population cohort of 33,281 laboratory …

The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term
COVID-19 symptoms expressed by a substantial proportion of patients is not well …

Long COVID has become a world-wide, non-communicable epidemic, caused by long-
lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection …

Summary Background Post COVID-19 condition (PCC), as defined by WHO, refers to a wide
range of new, returning, or ongoing health problems in people who have had COVID-19 …

Long-COVID prevalence estimates vary widely and should take account of symptoms that
would have occurred anyway. Here we determine the prevalence of symptoms attributable …

Objective: As the number of recovering COVID-19 patients increases worldwide, the
persistence of symptoms and signs through the post-acute phase indicates an urgent need …

Abstract The International Severe Acute Respiratory and Emerging Infection Consortium
(ISARIC) COVID-19 dataset is one of the largest international databases of prospectively …

Previous studies on the natural history of long-COVID have been few and selective. Without
comparison groups, disease progression cannot be differentiated from symptoms originating …